Relatively recent advancements in the understanding of the pathophysiology of CKD-associated anemia has led to the discovery of viable treatment targets, yet nephrologists may lack awareness of these therapeutic developments. Additionally, certain healthcare disparities may limit comprehensive management across the broader population of patients with anemia and CKD, consequently increasing the global burden of this complication. To ensure appropriate care and outcomes for patients, nephrologists require up-to-date education on the pathophysiology of anemia and CKD, burden of disease, current and emerging treatment options, and barriers to care.

This educational activity has been designed for US-based nephrology healthcare professionals (HCPs), including nephrology physicians, physician assistants (PAs), nurse practitioners (NPs), and residents.